A detailed history of Janiczek Wealth Management, LLC transactions in Atai Life Sciences N.V. stock. As of the latest transaction made, Janiczek Wealth Management, LLC holds 212 shares of ATAI stock, worth $252. This represents 0.0% of its overall portfolio holdings.

Number of Shares
212
Previous 212 -0.0%
Holding current value
$252
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Oct 17, 2022

BUY
$3.14 - $4.87 $351 - $545
112 Added 112.0%
212 $1,000
Q1 2022

May 05, 2022

BUY
$4.66 - $7.66 $466 - $766
100 New
100 $1,000

Others Institutions Holding ATAI

About ATAI Life Sciences N.V.


  • Ticker ATAI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 165,875,008
  • Market Cap $197M
  • Description
  • Atai Life Sciences N.V., through its subsidiary, ATAI Life Sciences AG, operates as a clinical-stage biopharmaceutical company. It engages in developing various therapeutic candidates that focuses on various mental health disorders. The company's therapeutic candidates include PCN-101, a subcutaneous formulation of R-ketamine for the treatment o...
More about ATAI
Track This Portfolio

Track Janiczek Wealth Management, LLC Portfolio

Follow Janiczek Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Janiczek Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Janiczek Wealth Management, LLC with notifications on news.